Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lia Laura Lewis Ximenez de Souza Rodrigues"'
Autor:
Vanessa D Costa, Carlos E Brandão-Mello, Estevão P Nunes, Pedro Guilherme Corôa Dos Santos Silva, Lia Laura Lewis Ximenez de Souza Rodrigues, Elisabeth Lampe, Francisco Campello do Amaral Mello
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216327 (2019)
The selection of viral strains with resistance-associated substitutions at hepatitis C virus (HCV) NS5A and NS5B genes is considered one of the limiting factors for achieving sustained virologic response (SVR) to combination of direct-acting antivira
Externí odkaz:
https://doaj.org/article/64c32fabef904e8f8762cf1f34d5275c
Autor:
Vanessa Duarte da Costa, Paulo Sergio Fonseca de Sousa, Carlos Eduardo Brandão-Mello, Lia Laura Lewis Ximenez de Souza Rodrigues, Elisabeth Lampe, Francisco C. A. Mello, Estevão Portela Nunes, Nathália Delvaux
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 43:700-706
Summary Background and aims Treatment for hepatitis C has evolved significantly with the licensing of direct-acting antiviral drugs (DAAs). However, one of the limiting factors of the effectiveness of antiviral therapy with protease inhibitors (PIs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6554bcf5174fea8849730829a36c694
https://doi.org/10.1016/j.clinre.2019.02.009
https://doi.org/10.1016/j.clinre.2019.02.009
Recombinant VP1 protein as a potential marker for the diagnosis of acute hepatitis A virus infection
Autor:
Lia Laura Lewis Ximenez de Souza Rodrigues, Haroldo Cid da Silva Junior, Marco Alberto Medeiros, Edimilson Domingos da Silva
Publikováno v:
Journal of Virological Methods. 245:1-4
Since hepatitis A virus (HAV) production is time-consuming and expensive, the use of recombinant proteins may represent an alternative source of antigens for diagnostic purposes. The present study aimed to express, purify and evaluate the potential o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8aef010c5b1c3786e00f6cbc51ed4be
https://doi.org/10.1016/j.jviromet.2017.03.005
https://doi.org/10.1016/j.jviromet.2017.03.005
Autor:
Costa, Vanessa D.1 vduarte@ioc.fiocruz.br, Brandão-Mello, Carlos E.2, Nunes, Estevão P.3, dos Santos Silva, Pedro Guilherme Corôa1, de Souza Rodrigues, Lia Laura Lewis Ximenez1, Lampe, Elisabeth1, do Amaral Mello, Francisco Campello1
Publikováno v:
PLoS ONE. 5/7/2019, Vol. 14 Issue 5, p1-12. 12p.
Autor:
Baylis, Sally A., Hanschmann, Kay‐Martin O., Schnierle, Barbara S., Trösemeier, Jan‐Hendrik, Blümel, Johannes
Publikováno v:
Transfusion; Mar2017, Vol. 57 Issue 3pt2, p748-761, 14p
Publikováno v:
Biblioteca Digital de Teses e Dissertações da UERJUniversidade do Estado do Rio de JaneiroUERJ.
Estima-se que a prevalência global da população mundial com hepatite C é de 3%. Pouco se sabe sobre a resposta ao tratamento com respeito à resistência viral. Algumas mutações no fragmento de 109 aminoácidos da NS5B são associadas com resis